| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography | 87 | 2016 | 1863 | 2.810 |
Why?
|
| Ultrasonography, Mammary | 21 | 2015 | 380 | 2.360 |
Why?
|
| Biopsy, Needle | 41 | 2016 | 1363 | 2.040 |
Why?
|
| Ultrasonography, Interventional | 9 | 2019 | 429 | 1.580 |
Why?
|
| Breast Neoplasms | 59 | 2016 | 15694 | 1.470 |
Why?
|
| Breast Diseases | 8 | 2013 | 201 | 0.880 |
Why?
|
| Biopsy, Fine-Needle | 6 | 2019 | 690 | 0.790 |
Why?
|
| Carcinoma, Ductal, Breast | 9 | 2016 | 1216 | 0.730 |
Why?
|
| Mammography | 12 | 2014 | 1010 | 0.720 |
Why?
|
| Lymphatic Metastasis | 27 | 2019 | 4844 | 0.700 |
Why?
|
| Lymph Nodes | 15 | 2019 | 2967 | 0.690 |
Why?
|
| Breast | 11 | 2016 | 1344 | 0.680 |
Why?
|
| Image-Guided Biopsy | 2 | 2019 | 327 | 0.620 |
Why?
|
| Hand | 9 | 1989 | 170 | 0.570 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2016 | 134 | 0.540 |
Why?
|
| Image Enhancement | 3 | 2012 | 561 | 0.510 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 2 | 2015 | 167 | 0.500 |
Why?
|
| Tendons | 8 | 2000 | 84 | 0.500 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2014 | 133 | 0.460 |
Why?
|
| Carcinoma, Lobular | 5 | 2014 | 611 | 0.460 |
Why?
|
| Foreign Bodies | 9 | 1988 | 145 | 0.430 |
Why?
|
| Carcinoma | 12 | 2006 | 2578 | 0.420 |
Why?
|
| Ultrasonography, Doppler, Color | 6 | 2006 | 100 | 0.400 |
Why?
|
| Catheter Ablation | 6 | 2014 | 620 | 0.390 |
Why?
|
| Soft Tissue Neoplasms | 10 | 2003 | 882 | 0.390 |
Why?
|
| Ultrasonography, Doppler | 4 | 2015 | 231 | 0.360 |
Why?
|
| Female | 95 | 2019 | 141928 | 0.330 |
Why?
|
| Granular Cell Tumor | 2 | 2006 | 22 | 0.320 |
Why?
|
| Fibrocystic Breast Disease | 3 | 1999 | 45 | 0.320 |
Why?
|
| Humans | 146 | 2019 | 261506 | 0.310 |
Why?
|
| Muscular Diseases | 3 | 2000 | 161 | 0.310 |
Why?
|
| Skin | 5 | 1995 | 1259 | 0.300 |
Why?
|
| Skin Diseases | 3 | 1995 | 349 | 0.290 |
Why?
|
| Prostheses and Implants | 5 | 2006 | 295 | 0.280 |
Why?
|
| Thyroid Gland | 5 | 2016 | 355 | 0.280 |
Why?
|
| Cysts | 7 | 2002 | 197 | 0.270 |
Why?
|
| Adult | 65 | 2019 | 77950 | 0.270 |
Why?
|
| Muscles | 3 | 2000 | 416 | 0.270 |
Why?
|
| Middle Aged | 66 | 2019 | 86204 | 0.260 |
Why?
|
| Radiosurgery | 1 | 2014 | 1330 | 0.260 |
Why?
|
| Prostatic Diseases | 5 | 1985 | 30 | 0.260 |
Why?
|
| Connective Tissue Diseases | 2 | 1995 | 50 | 0.250 |
Why?
|
| Ultrasonics | 4 | 1987 | 69 | 0.250 |
Why?
|
| Transducers | 5 | 2014 | 59 | 0.250 |
Why?
|
| Diagnosis, Differential | 12 | 2016 | 4744 | 0.240 |
Why?
|
| Prostate | 9 | 1995 | 1088 | 0.240 |
Why?
|
| Neoplasm Staging | 19 | 2015 | 13658 | 0.230 |
Why?
|
| Thyroid Neoplasms | 6 | 2016 | 1866 | 0.230 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2004 | 674 | 0.210 |
Why?
|
| Aged | 48 | 2019 | 70117 | 0.210 |
Why?
|
| Tendon Injuries | 2 | 2000 | 31 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2016 | 7702 | 0.200 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2004 | 436 | 0.190 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 1993 | 72 | 0.180 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 6009 | 0.180 |
Why?
|
| Neoplasm Invasiveness | 6 | 2016 | 3981 | 0.180 |
Why?
|
| Axilla | 10 | 2014 | 902 | 0.180 |
Why?
|
| Fibroadenoma | 4 | 1999 | 25 | 0.170 |
Why?
|
| Tendinopathy | 4 | 1988 | 16 | 0.170 |
Why?
|
| Prostatic Neoplasms | 8 | 1995 | 5767 | 0.160 |
Why?
|
| Phantoms, Imaging | 3 | 2005 | 1271 | 0.160 |
Why?
|
| MEDLINE | 1 | 1998 | 36 | 0.160 |
Why?
|
| Lipoma | 2 | 1991 | 89 | 0.160 |
Why?
|
| Muscle, Skeletal | 3 | 2005 | 1270 | 0.160 |
Why?
|
| Cryosurgery | 2 | 2016 | 167 | 0.150 |
Why?
|
| Abdominal Neoplasms | 3 | 1984 | 231 | 0.150 |
Why?
|
| Athletic Injuries | 4 | 1995 | 97 | 0.150 |
Why?
|
| Glomus Tumor | 2 | 1988 | 27 | 0.140 |
Why?
|
| Sensitivity and Specificity | 11 | 2014 | 4971 | 0.140 |
Why?
|
| Microwaves | 2 | 2014 | 32 | 0.140 |
Why?
|
| Aged, 80 and over | 18 | 2016 | 29902 | 0.140 |
Why?
|
| Intraoperative Care | 2 | 2014 | 259 | 0.140 |
Why?
|
| Retrospective Studies | 20 | 2019 | 37905 | 0.140 |
Why?
|
| Fingers | 2 | 1988 | 120 | 0.130 |
Why?
|
| Mammaplasty | 4 | 2003 | 780 | 0.130 |
Why?
|
| Pharynx | 3 | 2019 | 153 | 0.130 |
Why?
|
| Adenofibroma | 3 | 1989 | 20 | 0.130 |
Why?
|
| Radiography | 5 | 1995 | 1904 | 0.130 |
Why?
|
| Biopsy | 5 | 2010 | 3443 | 0.120 |
Why?
|
| Soft Tissue Injuries | 1 | 1995 | 51 | 0.120 |
Why?
|
| Leg | 2 | 1993 | 226 | 0.120 |
Why?
|
| Cryotherapy | 1 | 2014 | 67 | 0.120 |
Why?
|
| Ultrasonic Therapy | 1 | 2014 | 55 | 0.120 |
Why?
|
| Photography | 1 | 1995 | 139 | 0.120 |
Why?
|
| Myositis Ossificans | 2 | 1995 | 30 | 0.120 |
Why?
|
| Prostatic Hyperplasia | 4 | 1989 | 210 | 0.120 |
Why?
|
| Mastectomy, Segmental | 3 | 2014 | 1026 | 0.120 |
Why?
|
| Breast Cyst | 1 | 2013 | 2 | 0.120 |
Why?
|
| Electroporation | 1 | 2014 | 126 | 0.120 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2013 | 10 | 0.120 |
Why?
|
| Silicones | 1 | 1993 | 54 | 0.120 |
Why?
|
| Myxoma | 1 | 1994 | 63 | 0.120 |
Why?
|
| Lymph Node Excision | 6 | 2014 | 1959 | 0.120 |
Why?
|
| Adolescent | 18 | 2019 | 31252 | 0.110 |
Why?
|
| Periodicals as Topic | 1 | 1998 | 338 | 0.110 |
Why?
|
| Mouth | 1 | 2014 | 122 | 0.110 |
Why?
|
| Fat Necrosis | 1 | 2013 | 63 | 0.110 |
Why?
|
| Male | 44 | 2019 | 123000 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2014 | 10035 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2013 | 1648 | 0.110 |
Why?
|
| Prostatectomy | 2 | 1995 | 962 | 0.110 |
Why?
|
| Hamartoma | 1 | 2013 | 115 | 0.110 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2014 | 171 | 0.100 |
Why?
|
| Granuloma | 1 | 1993 | 154 | 0.100 |
Why?
|
| Artifacts | 1 | 1995 | 532 | 0.100 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2014 | 304 | 0.100 |
Why?
|
| Peripheral Nerves | 2 | 1993 | 159 | 0.100 |
Why?
|
| Bone Cysts | 1 | 1991 | 14 | 0.100 |
Why?
|
| Calcaneus | 1 | 1991 | 17 | 0.100 |
Why?
|
| Rhabdomyolysis | 2 | 1995 | 52 | 0.100 |
Why?
|
| Tenosynovitis | 5 | 1989 | 14 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 1995 | 529 | 0.100 |
Why?
|
| Adenocarcinoma | 8 | 2003 | 7789 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2013 | 925 | 0.090 |
Why?
|
| Nipples | 1 | 1991 | 132 | 0.090 |
Why?
|
| Laser Therapy | 1 | 2014 | 411 | 0.090 |
Why?
|
| Achilles Tendon | 2 | 1987 | 11 | 0.090 |
Why?
|
| Saphenous Vein | 1 | 1990 | 95 | 0.090 |
Why?
|
| Hyperthermia, Induced | 1 | 2014 | 510 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1993 | 393 | 0.090 |
Why?
|
| Phyllodes Tumor | 1 | 1989 | 62 | 0.090 |
Why?
|
| Palpation | 4 | 2000 | 49 | 0.080 |
Why?
|
| False Negative Reactions | 4 | 2002 | 275 | 0.080 |
Why?
|
| Follow-Up Studies | 11 | 2014 | 14889 | 0.080 |
Why?
|
| Siphonaptera | 1 | 2008 | 8 | 0.080 |
Why?
|
| Calcinosis | 2 | 2000 | 423 | 0.080 |
Why?
|
| Pathology | 1 | 1989 | 101 | 0.080 |
Why?
|
| Toes | 1 | 2008 | 46 | 0.080 |
Why?
|
| Urethral Obstruction | 1 | 1989 | 56 | 0.080 |
Why?
|
| Neurofibroma | 1 | 1988 | 31 | 0.080 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2013 | 830 | 0.080 |
Why?
|
| Pelvic Neoplasms | 1 | 1990 | 189 | 0.080 |
Why?
|
| Thumb | 1 | 1988 | 35 | 0.080 |
Why?
|
| Insect Bites and Stings | 1 | 2008 | 43 | 0.080 |
Why?
|
| Surgical Flaps | 2 | 2006 | 927 | 0.080 |
Why?
|
| Patella | 2 | 1987 | 44 | 0.080 |
Why?
|
| Rupture | 4 | 1995 | 61 | 0.080 |
Why?
|
| Bone Wires | 1 | 1987 | 9 | 0.080 |
Why?
|
| Orthopedic Fixation Devices | 1 | 1987 | 20 | 0.080 |
Why?
|
| Foot Diseases | 1 | 1988 | 52 | 0.080 |
Why?
|
| Surgical Equipment | 1 | 1987 | 17 | 0.080 |
Why?
|
| Extremities | 2 | 1991 | 303 | 0.080 |
Why?
|
| Telemedicine | 1 | 2013 | 471 | 0.080 |
Why?
|
| Feasibility Studies | 4 | 2013 | 2292 | 0.080 |
Why?
|
| Neurilemmoma | 1 | 1988 | 127 | 0.070 |
Why?
|
| Oral Surgical Procedures | 1 | 2007 | 32 | 0.070 |
Why?
|
| Mammary Glands, Human | 1 | 2008 | 184 | 0.070 |
Why?
|
| Prospective Studies | 12 | 2014 | 12873 | 0.070 |
Why?
|
| Leprosy | 1 | 1987 | 33 | 0.070 |
Why?
|
| Dog Diseases | 1 | 1987 | 73 | 0.070 |
Why?
|
| Foreign-Body Migration | 1 | 1987 | 117 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2006 | 60 | 0.070 |
Why?
|
| Catheterization | 1 | 1989 | 410 | 0.070 |
Why?
|
| Urethra | 1 | 1986 | 144 | 0.070 |
Why?
|
| Foot | 1 | 1986 | 104 | 0.070 |
Why?
|
| Urinary Catheterization | 1 | 1986 | 117 | 0.070 |
Why?
|
| Observer Variation | 2 | 2014 | 671 | 0.070 |
Why?
|
| Adenoma | 1 | 1991 | 716 | 0.070 |
Why?
|
| False Positive Reactions | 4 | 2003 | 355 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1989 | 410 | 0.070 |
Why?
|
| Adenocarcinoma, Scirrhous | 1 | 1984 | 1 | 0.060 |
Why?
|
| Linitis Plastica | 1 | 1984 | 13 | 0.060 |
Why?
|
| Echinococcosis, Hepatic | 1 | 1983 | 6 | 0.060 |
Why?
|
| Equipment Design | 2 | 2000 | 1204 | 0.060 |
Why?
|
| Age of Onset | 1 | 2006 | 827 | 0.060 |
Why?
|
| Knee Joint | 1 | 1984 | 161 | 0.060 |
Why?
|
| Liver Neoplasms | 4 | 2005 | 4557 | 0.060 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2003 | 171 | 0.060 |
Why?
|
| Dermatitis | 2 | 1993 | 60 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2006 | 502 | 0.060 |
Why?
|
| Thyroid Nodule | 1 | 2003 | 92 | 0.060 |
Why?
|
| Skin Neoplasms | 4 | 1995 | 4654 | 0.060 |
Why?
|
| Urinary Bladder Diseases | 2 | 1984 | 45 | 0.060 |
Why?
|
| Preoperative Care | 3 | 2003 | 1529 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2007 | 3890 | 0.050 |
Why?
|
| Water | 1 | 1984 | 361 | 0.050 |
Why?
|
| Genital Diseases, Male | 1 | 1982 | 27 | 0.050 |
Why?
|
| Suction | 1 | 2002 | 104 | 0.050 |
Why?
|
| Radiotherapy | 1 | 1989 | 1824 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2014 | 15862 | 0.050 |
Why?
|
| Child | 12 | 2019 | 29154 | 0.050 |
Why?
|
| Child, Preschool | 8 | 2019 | 16273 | 0.050 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2014 | 1415 | 0.050 |
Why?
|
| Thyroidectomy | 1 | 2003 | 486 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 2 | 2007 | 4975 | 0.050 |
Why?
|
| Hodgkin Disease | 1 | 1989 | 1429 | 0.050 |
Why?
|
| Electronics, Medical | 1 | 2000 | 15 | 0.050 |
Why?
|
| Stainless Steel | 1 | 1999 | 26 | 0.050 |
Why?
|
| Technology, Radiologic | 1 | 2000 | 80 | 0.050 |
Why?
|
| Vaginal Neoplasms | 1 | 2001 | 152 | 0.040 |
Why?
|
| Software | 2 | 2013 | 1321 | 0.040 |
Why?
|
| Melanoma | 3 | 1995 | 5317 | 0.040 |
Why?
|
| Treatment Outcome | 7 | 2016 | 32848 | 0.040 |
Why?
|
| Cytodiagnosis | 3 | 2003 | 220 | 0.040 |
Why?
|
| Intestinal Neoplasms | 1 | 2001 | 189 | 0.040 |
Why?
|
| Physical Examination | 4 | 2003 | 299 | 0.040 |
Why?
|
| Predictive Value of Tests | 5 | 2016 | 4892 | 0.040 |
Why?
|
| Young Adult | 2 | 2016 | 21445 | 0.040 |
Why?
|
| Calibration | 1 | 2000 | 337 | 0.040 |
Why?
|
| Disease-Free Survival | 5 | 2016 | 10001 | 0.040 |
Why?
|
| Hemangioma | 2 | 1993 | 154 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2005 | 941 | 0.040 |
Why?
|
| Anticarcinogenic Agents | 1 | 2000 | 362 | 0.040 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2001 | 301 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2001 | 4298 | 0.040 |
Why?
|
| Computer Communication Networks | 1 | 1998 | 44 | 0.040 |
Why?
|
| Tretinoin | 1 | 2000 | 623 | 0.040 |
Why?
|
| Neoplasms | 2 | 1995 | 15193 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1990 | 2390 | 0.040 |
Why?
|
| United States | 2 | 2013 | 15433 | 0.040 |
Why?
|
| Combined Modality Therapy | 5 | 2014 | 8865 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 14289 | 0.040 |
Why?
|
| Hematoma | 2 | 1993 | 160 | 0.040 |
Why?
|
| Synovial Cyst | 2 | 1988 | 6 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1996 | 134 | 0.040 |
Why?
|
| Mastectomy | 1 | 2003 | 1534 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2000 | 876 | 0.040 |
Why?
|
| Tongue Neoplasms | 1 | 1998 | 246 | 0.030 |
Why?
|
| Angiomyolipoma | 1 | 1996 | 31 | 0.030 |
Why?
|
| Seminal Vesicles | 2 | 1986 | 152 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2003 | 1162 | 0.030 |
Why?
|
| Prostatitis | 2 | 1985 | 18 | 0.030 |
Why?
|
| Knee Injuries | 2 | 1987 | 63 | 0.030 |
Why?
|
| Sprains and Strains | 1 | 1995 | 12 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2000 | 840 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 1994 | 35 | 0.030 |
Why?
|
| Hernia | 1 | 1995 | 46 | 0.030 |
Why?
|
| Prognosis | 5 | 2014 | 21713 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 1984 | 2341 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 1998 | 5437 | 0.030 |
Why?
|
| Joint Diseases | 1 | 1995 | 71 | 0.030 |
Why?
|
| Orchiectomy | 1 | 1995 | 214 | 0.030 |
Why?
|
| Postoperative Period | 2 | 2006 | 665 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1995 | 306 | 0.030 |
Why?
|
| Soft Tissue Infections | 1 | 1995 | 102 | 0.030 |
Why?
|
| Keratosis | 1 | 1993 | 39 | 0.030 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 833 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 4320 | 0.030 |
Why?
|
| Silicone Elastomers | 1 | 1993 | 49 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 1995 | 475 | 0.030 |
Why?
|
| Contrast Media | 1 | 2000 | 1472 | 0.030 |
Why?
|
| Epidermis | 1 | 1993 | 188 | 0.030 |
Why?
|
| Nevus | 1 | 1993 | 107 | 0.030 |
Why?
|
| Cicatrix | 1 | 1995 | 208 | 0.030 |
Why?
|
| Psoriasis | 1 | 1993 | 126 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2005 | 2027 | 0.030 |
Why?
|
| Rectum | 2 | 1985 | 467 | 0.030 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2003 | 1833 | 0.030 |
Why?
|
| Neoplasms, Second Primary | 1 | 2001 | 1350 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 1984 | 2278 | 0.030 |
Why?
|
| Sarcoma, Kaposi | 1 | 1993 | 187 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 1994 | 354 | 0.030 |
Why?
|
| Antigens, CD | 1 | 1996 | 1385 | 0.030 |
Why?
|
| Actins | 1 | 1994 | 608 | 0.020 |
Why?
|
| Carcinoma, Basal Cell | 1 | 1993 | 272 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2001 | 1664 | 0.020 |
Why?
|
| Mycosis Fungoides | 1 | 1993 | 320 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 1989 | 70 | 0.020 |
Why?
|
| Synovitis | 1 | 1989 | 23 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 1995 | 769 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 1742 | 0.020 |
Why?
|
| Esophageal Neoplasms | 2 | 1993 | 3168 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 1989 | 85 | 0.020 |
Why?
|
| Internet | 1 | 2013 | 706 | 0.020 |
Why?
|
| Hyperpigmentation | 1 | 2008 | 32 | 0.020 |
Why?
|
| Bursitis | 1 | 1988 | 10 | 0.020 |
Why?
|
| Wrist | 1 | 1988 | 26 | 0.020 |
Why?
|
| Epidermal Cyst | 1 | 1988 | 46 | 0.020 |
Why?
|
| Hemangiosarcoma | 1 | 1990 | 234 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2003 | 3578 | 0.020 |
Why?
|
| Vagina | 1 | 1990 | 317 | 0.020 |
Why?
|
| Methods | 2 | 1984 | 189 | 0.020 |
Why?
|
| West Indies | 1 | 1987 | 8 | 0.020 |
Why?
|
| France | 1 | 1987 | 108 | 0.020 |
Why?
|
| Tropical Climate | 1 | 1987 | 51 | 0.020 |
Why?
|
| Liver | 2 | 1988 | 2961 | 0.020 |
Why?
|
| Osteoarthritis | 1 | 1987 | 94 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6207 | 0.020 |
Why?
|
| Electromagnetic Phenomena | 1 | 2005 | 18 | 0.020 |
Why?
|
| Drainage | 1 | 2008 | 416 | 0.020 |
Why?
|
| Survival Rate | 2 | 2014 | 12221 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2005 | 9180 | 0.020 |
Why?
|
| Calculi | 1 | 1985 | 14 | 0.020 |
Why?
|
| Urodynamics | 1 | 1985 | 57 | 0.020 |
Why?
|
| Dogs | 1 | 1987 | 1155 | 0.020 |
Why?
|
| Hyperplasia | 2 | 1999 | 557 | 0.020 |
Why?
|
| Chickens | 1 | 2005 | 523 | 0.020 |
Why?
|
| Urogenital System | 1 | 1984 | 59 | 0.020 |
Why?
|
| Urinary Tract | 1 | 1985 | 82 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1984 | 122 | 0.010 |
Why?
|
| Lymphography | 1 | 2003 | 51 | 0.010 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2003 | 82 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1996 | 2326 | 0.010 |
Why?
|
| Time Factors | 2 | 1990 | 12926 | 0.010 |
Why?
|
| Remission Induction | 2 | 2000 | 3569 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 2 | 1996 | 1165 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 310 | 0.010 |
Why?
|
| Echinococcosis | 1 | 1982 | 15 | 0.010 |
Why?
|
| Polymers | 1 | 1984 | 223 | 0.010 |
Why?
|
| Breast Self-Examination | 1 | 2002 | 16 | 0.010 |
Why?
|
| Rectal Neoplasms | 1 | 1990 | 1202 | 0.010 |
Why?
|
| Genitalia, Male | 1 | 1982 | 36 | 0.010 |
Why?
|
| Genital Neoplasms, Male | 1 | 1982 | 44 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1996 | 3022 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2007 | 2231 | 0.010 |
Why?
|
| Clavicle | 1 | 2001 | 65 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 1984 | 8223 | 0.010 |
Why?
|
| Quality Control | 1 | 2002 | 457 | 0.010 |
Why?
|
| Sarcoma | 1 | 1991 | 1725 | 0.010 |
Why?
|
| Pancreas | 1 | 1984 | 718 | 0.010 |
Why?
|
| Ranitidine | 1 | 2000 | 35 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7573 | 0.010 |
Why?
|
| Premedication | 1 | 2000 | 135 | 0.010 |
Why?
|
| Doxorubicin | 2 | 2000 | 3005 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 2003 | 584 | 0.010 |
Why?
|
| Esophagus | 2 | 1993 | 553 | 0.010 |
Why?
|
| Reoperation | 1 | 2003 | 1382 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2003 | 509 | 0.010 |
Why?
|
| Infant | 3 | 1984 | 13310 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 1982 | 575 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 418 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1999 | 208 | 0.010 |
Why?
|
| Glossectomy | 1 | 1998 | 40 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2003 | 7551 | 0.010 |
Why?
|
| Animals | 3 | 2008 | 59536 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1993 | 5542 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 7548 | 0.010 |
Why?
|
| Age Factors | 1 | 1986 | 5377 | 0.010 |
Why?
|
| Aneuploidy | 1 | 1998 | 369 | 0.010 |
Why?
|
| Elective Surgical Procedures | 1 | 1998 | 250 | 0.010 |
Why?
|
| S100 Proteins | 1 | 1996 | 181 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 2522 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 2992 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2000 | 1944 | 0.010 |
Why?
|
| Kidney | 1 | 1984 | 2146 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 3719 | 0.010 |
Why?
|
| Neck | 1 | 1998 | 383 | 0.010 |
Why?
|
| Mastectomy, Simple | 1 | 1995 | 58 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2000 | 1450 | 0.010 |
Why?
|
| Forecasting | 1 | 1998 | 694 | 0.010 |
Why?
|
| Dissection | 1 | 1995 | 156 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 3890 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1993 | 40 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1984 | 5112 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1998 | 1945 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1994 | 756 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2000 | 1996 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2000 | 3001 | 0.010 |
Why?
|
| Research Design | 1 | 2000 | 1544 | 0.010 |
Why?
|
| Patient Selection | 1 | 2000 | 2055 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 4988 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1998 | 1910 | 0.010 |
Why?
|
| Etoposide | 1 | 1993 | 870 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1994 | 1391 | 0.010 |
Why?
|
| Proctoscopy | 1 | 1990 | 17 | 0.010 |
Why?
|
| Nephrectomy | 1 | 1996 | 779 | 0.010 |
Why?
|
| Logistic Models | 1 | 1998 | 3441 | 0.010 |
Why?
|
| Lymphatic Diseases | 1 | 1991 | 128 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1993 | 543 | 0.010 |
Why?
|
| Risk Factors | 2 | 1998 | 17523 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 1999 | 2403 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2000 | 6869 | 0.000 |
Why?
|
| Body Mass Index | 1 | 1994 | 2203 | 0.000 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1990 | 551 | 0.000 |
Why?
|
| Clinical Competence | 1 | 1994 | 1270 | 0.000 |
Why?
|
| Cisplatin | 1 | 1993 | 2432 | 0.000 |
Why?
|
| Biomarkers | 1 | 1996 | 5047 | 0.000 |
Why?
|
| Ureterocele | 1 | 1984 | 8 | 0.000 |
Why?
|
| Pelvis | 1 | 1984 | 362 | 0.000 |
Why?
|
| Biomarkers, Tumor | 1 | 2000 | 10331 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1994 | 4367 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1984 | 589 | 0.000 |
Why?
|